4880 — CellSource Co Cashflow Statement
0.000.00%
Last trade - 00:00- ¥13bn
- ¥9bn
- ¥4bn
Annual cashflow statement for CellSource Co, fiscal year end - October 31st, JPY millions except per share, conversion factor applied.
2020 October 31st | 2021 October 31st | 2022 October 31st | 2023 October 31st | 2024 October 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 413 | 1,006 | 1,584 | 1,240 | 295 |
| Depreciation | |||||
| Non-Cash Items | 46.2 | 19.3 | 63.3 | 48.3 | 159 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -155 | -158 | -845 | -505 | -4.54 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 330 | 898 | 848 | 847 | 592 |
| Capital Expenditures | -32.7 | -61.5 | -99.2 | -359 | -540 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -25.1 | -195 | -70.2 | -265 | -75.3 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -57.8 | -256 | -169 | -624 | -615 |
| Financing Cash Flow Items | -1.56 | 0.802 | 0.252 | -6 | -23.4 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 153 | 9.35 | 14.4 | 1,449 | -437 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 423 | 652 | 714 | 1,657 | -460 |